ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
w_i_z_z_a
|
163 |
81K |
22 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
163
|
81K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
w_i_z_z_a
|
32 |
18K |
15 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
32
|
18K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
w_i_z_z_a
|
250 |
81K |
9 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
250
|
81K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Correction to ASX announcement
|
|
w_i_z_z_a
|
70 |
20K |
13 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
70
|
20K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Why you should vote YES - a professional investor's perspective
|
|
w_i_z_z_a
|
208 |
56K |
2 |
20/08/22 |
20/08/22 |
ASX - By Stock
|
208
|
56K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Dispatch of Supplementary Scheme Booklet
|
|
w_i_z_z_a
|
13 |
4.1K |
8 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
13
|
4.1K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Another RAP Hat for $1.50?
|
|
w_i_z_z_a
|
18 |
6.0K |
19 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
18
|
6.0K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
What to expect if Pfizer's takeover fails
|
|
w_i_z_z_a
|
108 |
23K |
15 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
108
|
23K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
w_i_z_z_a
|
446 |
98K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
446
|
98K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
w_i_z_z_a
|
123 |
36K |
10 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
w_i_z_z_a
|
123 |
36K |
18 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
123
|
36K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
w_i_z_z_a
|
446 |
98K |
19 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
446
|
98K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
w_i_z_z_a
|
151 |
45K |
16 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
151
|
45K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
w_i_z_z_a
|
151 |
50K |
19 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
w_i_z_z_a
|
126 |
37K |
14 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Proposed EGM and VOTE THEM OUT
|
|
w_i_z_z_a
|
12 |
3.4K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
12
|
3.4K
|
2
|
|
ASX - By Stock
|
RAP |
Proposed EGM and VOTE THEM OUT
|
|
w_i_z_z_a
|
12 |
3.4K |
13 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
12
|
3.4K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
w_i_z_z_a
|
425 |
126K |
34 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
126K
|
34
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
w_i_z_z_a
|
377 |
143K |
10 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
377
|
143K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
w_i_z_z_a
|
377 |
143K |
32 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
143K
|
32
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
w_i_z_z_a
|
3.3K |
2.5M |
7 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
w_i_z_z_a
|
88 |
40K |
13 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
88
|
40K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
w_i_z_z_a
|
88 |
40K |
25 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
88
|
40K
|
25
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
w_i_z_z_a
|
98 |
45K |
14 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
98
|
45K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
w_i_z_z_a
|
98 |
45K |
15 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
98
|
45K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
w_i_z_z_a
|
466 |
161K |
5 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
466
|
161K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
w_i_z_z_a
|
466 |
161K |
6 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
466
|
161K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Pfizer Cash Received
|
|
w_i_z_z_a
|
16 |
8.3K |
3 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
16
|
8.3K
|
3
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Palladium-Platinum Discovery Investor Presentation
|
|
w_i_z_z_a
|
227 |
117K |
1 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
227
|
117K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Pfizer Cash Received
|
|
w_i_z_z_a
|
16 |
8.3K |
9 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
16
|
8.3K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
w_i_z_z_a
|
555 |
189K |
2 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
555
|
189K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Commentary on AGM questions.
|
|
w_i_z_z_a
|
125 |
53K |
11 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
125
|
53K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
What price gets your YES VOTE?
|
|
w_i_z_z_a
|
189 |
58K |
3 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
189
|
58K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
BOD Motive?
|
|
w_i_z_z_a
|
97 |
31K |
14 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
97
|
31K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
BOD Motive?
|
|
w_i_z_z_a
|
97 |
31K |
1 |
16/04/22 |
16/04/22 |
ASX - By Stock
|
97
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
What price gets your YES VOTE?
|
|
w_i_z_z_a
|
189 |
58K |
12 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
189
|
58K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
BOD Motive?
|
|
w_i_z_z_a
|
97 |
31K |
12 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
97
|
31K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
w_i_z_z_a
|
687 |
255K |
10 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
687
|
255K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
w_i_z_z_a
|
687 |
255K |
6 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
687
|
255K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
w_i_z_z_a
|
687 |
255K |
6 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
687
|
255K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
w_i_z_z_a
|
687 |
255K |
8 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
255K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
w_i_z_z_a
|
1.0K |
296K |
7 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
1.0K
|
296K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Takeover : pool your guesses !
|
|
w_i_z_z_a
|
36 |
12K |
5 |
20/02/22 |
20/02/22 |
ASX - By Stock
|
36
|
12K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Takeover : pool your guesses !
|
|
w_i_z_z_a
|
36 |
12K |
0 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
36
|
12K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Merger Markets Article
|
|
w_i_z_z_a
|
75 |
23K |
1 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
75
|
23K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Takeover : pool your guesses !
|
|
w_i_z_z_a
|
36 |
12K |
3 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
36
|
12K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Merger Markets Article
|
|
w_i_z_z_a
|
75 |
23K |
2 |
19/02/22 |
19/02/22 |
ASX - By Stock
|
75
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
w_i_z_z_a
|
141 |
45K |
2 |
13/02/22 |
13/02/22 |
ASX - By Stock
|
141
|
45K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
w_i_z_z_a
|
141 |
45K |
2 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
141
|
45K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
w_i_z_z_a
|
141 |
45K |
3 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
141
|
45K
|
3
|
|